589720 科创创新药ETF国泰
已收盘 11-16 15:00:00
资讯
新帖
简况
11月16日君实生物跌9.80%,科创创新药ETF国泰基金重仓该股
证券之星 · 11-16 16:47
11月16日君实生物跌9.80%,科创创新药ETF国泰基金重仓该股
11月13日成都先导跌7.00%,科创创新药ETF国泰基金重仓该股
证券之星 · 11-13
11月13日成都先导跌7.00%,科创创新药ETF国泰基金重仓该股
11月6日成都先导跌8.22%,科创创新药ETF国泰基金重仓该股
证券之星 · 11-06
11月6日成都先导跌8.22%,科创创新药ETF国泰基金重仓该股
11月5日成都先导涨7.61%,科创创新药ETF国泰基金重仓该股
证券之星 · 11-05
11月5日成都先导涨7.61%,科创创新药ETF国泰基金重仓该股
【ETF动向】11月3日科创创新药ETF国泰基金跌3%,份额增加2.11亿份
证券之星 · 11-04
【ETF动向】11月3日科创创新药ETF国泰基金跌3%,份额增加2.11亿份
10月30日皓元医药涨10.79%,科创创新药ETF国泰基金重仓该股
证券之星 · 10-30
10月30日皓元医药涨10.79%,科创创新药ETF国泰基金重仓该股
10月27日皓元医药跌6.00%,科创创新药ETF国泰基金重仓该股
证券之星 · 10-27
10月27日皓元医药跌6.00%,科创创新药ETF国泰基金重仓该股
【ETF动向】10月21日科创创新药ETF国泰基金涨0.37%,份额减少4300万份
证券之星 · 10-22
【ETF动向】10月21日科创创新药ETF国泰基金涨0.37%,份额减少4300万份
10月20日欧林生物涨6.46%,科创创新药ETF国泰基金重仓该股
证券之星 · 10-20
10月20日欧林生物涨6.46%,科创创新药ETF国泰基金重仓该股
10月16日皓元医药跌5.48%,科创创新药ETF国泰基金重仓该股
证券之星 · 10-16
10月16日皓元医药跌5.48%,科创创新药ETF国泰基金重仓该股
【ETF动向】10月15日科创创新药ETF国泰基金跌0.38%,份额增加1.46亿份
证券之星 · 10-16
【ETF动向】10月15日科创创新药ETF国泰基金跌0.38%,份额增加1.46亿份
【ETF动向】10月13日科创创新药ETF国泰基金跌2.06%,份额增加6600万份
证券之星 · 10-14
【ETF动向】10月13日科创创新药ETF国泰基金跌2.06%,份额增加6600万份
10月12日欧林生物跌5.25%,科创创新药ETF国泰基金重仓该股
证券之星 · 10-12
10月12日欧林生物跌5.25%,科创创新药ETF国泰基金重仓该股
【ETF动向】10月9日科创创新药ETF国泰基金跌0.82%,份额增加1.93亿份
证券之星 · 10-10
【ETF动向】10月9日科创创新药ETF国泰基金跌0.82%,份额增加1.93亿份
10月8日博瑞医药跌6.65%,科创创新药ETF国泰基金重仓该股
证券之星 · 10-08
10月8日博瑞医药跌6.65%,科创创新药ETF国泰基金重仓该股
ETF午评|上证指数涨0.27%,医药板块表现突出,疫苗ETF、科创创新药ETF涨3%
格隆汇 · 09-30
ETF午评|上证指数涨0.27%,医药板块表现突出,疫苗ETF、科创创新药ETF涨3%
【ETF动向】9月29日科创创新药ETF国泰基金涨0%,份额增加1.34亿份
证券之星 · 09-30
【ETF动向】9月29日科创创新药ETF国泰基金涨0%,份额增加1.34亿份
9月24日皓元医药跌6.19%,科创创新药ETF国泰基金重仓该股
证券之星 · 09-24
9月24日皓元医药跌6.19%,科创创新药ETF国泰基金重仓该股
9月23日皓元医药涨9.84%,科创创新药ETF国泰基金重仓该股
证券之星 · 09-23
9月23日皓元医药涨9.84%,科创创新药ETF国泰基金重仓该股
【ETF动向】9月21日科创创新药ETF国泰基金涨5.01%,份额减少3.53亿份
证券之星 · 09-22
【ETF动向】9月21日科创创新药ETF国泰基金涨5.01%,份额减少3.53亿份
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"589720","market":"SH","secType":"STK","nameCN":"科创创新药ETF国泰","latestPrice":0.746,"timestamp":1794812400000,"preClose":0.774,"halted":0,"volume":622549596,"delay":0,"changeRate":-0.0362,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.028,"latestTime":"11-16 15:00:00","open":0.773,"high":0.774,"low":0.742,"amount":467000000,"amplitude":0.0413,"askPrice":0.746,"askSize":7979,"bidPrice":0.745,"bidSize":26219,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794879000000},"marketStatusCode":5,"adr":0,"adjPreClose":0.774,"symbolType":"fund","openAndCloseTimeList":[[1794792600000,1794799800000],[1794805200000,1794812400000]],"highLimit":0.851,"lowLimit":0.697,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":0.204054,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/589720","defaultTab":"news","newsList":[{"id":"2683831694","title":"11月16日君实生物跌9.80%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2683831694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683831694?lang=zh_cn&edition=full","pubTime":"2026-11-16 16:47","pubTimestamp":1794818845,"startTime":"0","endTime":"0","summary":"证券之星消息,11月16日君实生物跌9.80%创60日新低,收盘报26.88元,换手率3.21%,成交量24.58万手,成交额6.78亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共23家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为41.96亿元,最新净值0.7743,较上一交易日下跌3.27%,近一年下跌19.95%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600022499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1583","589720","BK1515","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683573179","title":"11月13日成都先导跌7.00%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2683573179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683573179?lang=zh_cn&edition=full","pubTime":"2026-11-13 16:45","pubTimestamp":1794559507,"startTime":"0","endTime":"0","summary":"证券之星消息,11月13日成都先导跌7.00%,收盘报37.99元,换手率7.5%,成交量30.09万手,成交额11.59亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共20家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为41.96亿元,最新净值0.8005,较上一交易日下跌0.22%,近一年下跌14.63%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300030033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222","589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681597468","title":"11月6日成都先导跌8.22%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681597468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681597468?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:18","pubTimestamp":1793956736,"startTime":"0","endTime":"0","summary":"证券之星消息,11月6日成都先导跌8.22%,收盘报35.17元,换手率7.21%,成交量28.91万手,成交额10.51亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共20家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为41.96亿元,最新净值0.8153,较上一交易日上涨2.48%,近一年下跌13.01%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600028835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","589720","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681204462","title":"11月5日成都先导涨7.61%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681204462","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681204462?lang=zh_cn&edition=full","pubTime":"2026-11-05 16:52","pubTimestamp":1793868772,"startTime":"0","endTime":"0","summary":"证券之星消息,11月5日成都先导涨7.61%,收盘报38.32元,换手率8.94%,成交量35.85万手,成交额13.5亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共20家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为41.96亿元,最新净值0.7956,较上一交易日上涨7.06%,近一年下跌16.23%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500029548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216","589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680052687","title":"【ETF动向】11月3日科创创新药ETF国泰基金跌3%,份额增加2.11亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2680052687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680052687?lang=zh_cn&edition=full","pubTime":"2026-11-04 06:42","pubTimestamp":1793745753,"startTime":"0","endTime":"0","summary":"证券之星消息,11月3日,科创创新药ETF国泰基金(589720)跌3%,成交额5.65亿元。当日份额增加了2.11亿份,最新份额为58.58亿份,近20个交易日份额增加9.13亿份。当日资金净流入1901.16万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为43.53亿元。科创创新药ETF国泰基金跟踪标的为上证科创板创新药指数,成立(2025-07-23)以来超额回报为-1.07%,近一个月超额回报为-0.01%,管理人为国泰基金公司,基金经理为麻绎文。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400008825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679293028","title":"10月30日皓元医药涨10.79%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2679293028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679293028?lang=zh_cn&edition=full","pubTime":"2026-10-30 16:54","pubTimestamp":1793350477,"startTime":"0","endTime":"0","summary":"证券之星消息,10月30日皓元医药涨10.79%,收盘报92.09元,换手率5.07%,成交量10.81万手,成交额9.73亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共54家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为41.96亿元,最新净值0.7546,较上一交易日下跌1.78%,近一年下跌19.16%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000041391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720","688131","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678112103","title":"10月27日皓元医药跌6.00%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2678112103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678112103?lang=zh_cn&edition=full","pubTime":"2026-10-27 16:48","pubTimestamp":1793090924,"startTime":"0","endTime":"0","summary":"证券之星消息,10月27日皓元医药跌6.00%,收盘报77.81元,换手率2.44%,成交量5.19万手,成交额4.17亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共40家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为41.96亿元,最新净值0.7991,较上一交易日下跌1.75%,近一年下跌14.01%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700031481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","589720","688131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677983593","title":"【ETF动向】10月21日科创创新药ETF国泰基金涨0.37%,份额减少4300万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2677983593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677983593?lang=zh_cn&edition=full","pubTime":"2026-10-22 06:35","pubTimestamp":1792622124,"startTime":"0","endTime":"0","summary":"证券之星消息,10月21日,科创创新药ETF国泰基金(589720)涨0.37%,成交额4.99亿元。当日份额减少了4300万份,最新份额为53.83亿份,近20个交易日份额增加7100万份。当日资金净流出1636.07万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为43.57亿元。科创创新药ETF国泰基金跟踪标的为上证科创板创新药指数,成立(2025-07-23)以来超额回报为-1.21%,近一个月超额回报为-0.08%,管理人为国泰基金公司,基金经理为麻绎文。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200004974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676665397","title":"10月20日欧林生物涨6.46%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676665397","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676665397?lang=zh_cn&edition=full","pubTime":"2026-10-20 16:28","pubTimestamp":1792484906,"startTime":"0","endTime":"0","summary":"证券之星消息,10月20日欧林生物涨6.46%,收盘报27.04元,换手率1.16%,成交量4.71万手,成交额1.28亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为21.97亿元,最新净值0.7911,较上一交易日上涨0.57%,近一年下跌15.29%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000024466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319","589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675562252","title":"10月16日皓元医药跌5.48%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675562252","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675562252?lang=zh_cn&edition=full","pubTime":"2026-10-16 16:31","pubTimestamp":1792139480,"startTime":"0","endTime":"0","summary":"证券之星消息,10月16日皓元医药跌5.48%,收盘报81.43元,换手率2.81%,成交量5.99万手,成交额5.07亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共28家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为21.97亿元,最新净值0.7888,较上一交易日下跌0.6%,近一年下跌16.32%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600027874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688131","589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675553298","title":"【ETF动向】10月15日科创创新药ETF国泰基金跌0.38%,份额增加1.46亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2675553298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675553298?lang=zh_cn&edition=full","pubTime":"2026-10-16 06:34","pubTimestamp":1792103682,"startTime":"0","endTime":"0","summary":"证券之星消息,10月15日,科创创新药ETF国泰基金(589720)跌0.38%,成交额6.21亿元。当日份额增加了1.46亿份,最新份额为54.93亿份,近20个交易日份额增加2700万份。当日资金净流入8950万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为43.33亿元。科创创新药ETF国泰基金跟踪标的为上证科创板创新药指数,成立(2025-07-23)以来超额回报为-1.16%,近一个月超额回报为-0.07%,管理人为国泰基金公司,基金经理为麻绎文。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600005763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675975398","title":"【ETF动向】10月13日科创创新药ETF国泰基金跌2.06%,份额增加6600万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2675975398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675975398?lang=zh_cn&edition=full","pubTime":"2026-10-14 06:34","pubTimestamp":1791930852,"startTime":"0","endTime":"0","summary":"证券之星消息,10月13日,科创创新药ETF国泰基金(589720)跌2.06%,成交额6.75亿元。当日份额增加了6600万份,最新份额为53.66亿份,近20个交易日份额增加1.26亿份。当日资金净流出2773.29万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为43.38亿元。科创创新药ETF国泰基金跟踪标的为上证科创板创新药指数,成立(2025-07-23)以来超额回报为-1.18%,近一个月超额回报为-0.1%,管理人为国泰基金公司,基金经理为麻绎文。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400005192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674647878","title":"10月12日欧林生物跌5.25%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674647878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674647878?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:40","pubTimestamp":1791794427,"startTime":"0","endTime":"0","summary":"证券之星消息,10月12日欧林生物跌5.25%,收盘报28.51元,换手率0.99%,成交量4.0万手,成交额1.16亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为21.97亿元,最新净值0.8498,较上一交易日下跌0.98%,近一年下跌14.78%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200021764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319","589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674862119","title":"【ETF动向】10月9日科创创新药ETF国泰基金跌0.82%,份额增加1.93亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2674862119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674862119?lang=zh_cn&edition=full","pubTime":"2026-10-10 06:35","pubTimestamp":1791585321,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日,科创创新药ETF国泰基金(589720)跌0.82%,成交额7.49亿元。当日份额增加了1.93亿份,最新份额为51.51亿份,近20个交易日份额增加200万份。当日资金净流入1.22亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为43.77亿元。科创创新药ETF国泰基金跟踪标的为上证科创板创新药指数,成立(2025-07-23)以来超额回报为-1.22%,近一个月超额回报为-0.01%,管理人为国泰基金公司,基金经理为麻绎文。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101000003263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673220530","title":"10月8日博瑞医药跌6.65%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673220530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673220530?lang=zh_cn&edition=full","pubTime":"2026-10-08 16:37","pubTimestamp":1791448656,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日博瑞医药跌6.65%,收盘报33.43元,换手率3.01%,成交量13.1万手,成交额4.47亿元。重仓博瑞医药的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共3家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800021274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688166","589720","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222655","title":"ETF午评|上证指数涨0.27%,医药板块表现突出,疫苗ETF、科创创新药ETF涨3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222655","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671222655?lang=zh_cn&edition=full","pubTime":"2026-09-30 11:39","pubTimestamp":1790739572,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0188","LU0067412154.USD","000001","BK0028","LU0072913022.USD","LU1226287529.USD","562860","159858","BK0278","BK0187","LU1993786604.SGD","LU0880133367.SGD","LU1655091616.SGD","LU0501845795.SGD","IE00B0JY6N72.USD","BK0201","LU1781817850.SGD","BK0012","159643","589720","LU1807302812.USD","BK0183","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671922854","title":"【ETF动向】9月29日科创创新药ETF国泰基金涨0%,份额增加1.34亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2671922854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671922854?lang=zh_cn&edition=full","pubTime":"2026-09-30 06:35","pubTimestamp":1790721308,"startTime":"0","endTime":"0","summary":"证券之星消息,9月29日,科创创新药ETF国泰基金(589720)涨0%,成交额6.32亿元。当日份额增加了1.34亿份,最新份额为49.45亿份,近20个交易日份额增加8200万份。当日资金净流入1.15亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为43.97亿元。科创创新药ETF国泰基金跟踪标的为上证科创板创新药指数,成立(2025-07-23)以来超额回报为-1.25%,近一个月超额回报为0.06%,管理人为国泰基金公司,基金经理为麻绎文。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000004736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669631874","title":"9月24日皓元医药跌6.19%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669631874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669631874?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:37","pubTimestamp":1790239071,"startTime":"0","endTime":"0","summary":"证券之星消息,9月24日皓元医药跌6.19%创60日新高,收盘报103.54元,换手率3.18%,成交量6.77万手,成交额7.24亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共28家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为21.97亿元,最新净值0.9454,较上一交易日上涨2.12%,近一年下跌6.99%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400028534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720","BK0216","688131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669109679","title":"9月23日皓元医药涨9.84%,科创创新药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669109679","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669109679?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:37","pubTimestamp":1790152655,"startTime":"0","endTime":"0","summary":"证券之星消息,9月23日皓元医药涨9.84%创60日新高,收盘报110.37元,换手率4.96%,成交量10.58万手,成交额11.45亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共28家,其中持有数量最多的公募基金为国泰基金的科创创新药ETF国泰。科创创新药ETF国泰目前规模为21.97亿元,最新净值0.9258,较上一交易日上涨0.33%,近一年下跌11.79%。科创创新药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300028183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688131","589720","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669319682","title":"【ETF动向】9月21日科创创新药ETF国泰基金涨5.01%,份额减少3.53亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669319682","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669319682?lang=zh_cn&edition=full","pubTime":"2026-09-22 06:35","pubTimestamp":1790030127,"startTime":"0","endTime":"0","summary":"证券之星消息,9月21日,科创创新药ETF国泰基金(589720)涨5.01%,成交额10.15亿元。当日份额减少了3.53亿份,最新份额为50.86亿份,近20个交易日份额增加3.92亿份。当日资金净流出9568.62万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为46.93亿元。科创创新药ETF国泰基金跟踪标的为上证科创板创新药指数,成立(2025-07-23)以来超额回报为-1.3%,近一个月超额回报为0.08%,管理人为国泰基金公司,基金经理为麻绎文。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200003356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["589720"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794857375428,"stockEarnings":[{"period":"1week","weight":-0.0698},{"period":"1month","weight":-0.0533},{"period":"3month","weight":-0.2333},{"period":"6month","weight":-0.1532},{"period":"1year","weight":-0.2253},{"period":"ytd","weight":-0.158}],"compareEarnings":[{"period":"1week","weight":-0.0159},{"period":"1month","weight":-0.0306},{"period":"3month","weight":-0.0972},{"period":"6month","weight":-0.1345},{"period":"1year","weight":-0.0972},{"period":"ytd","weight":-0.0923}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科创创新药ETF国泰(589720)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科创创新药ETF国泰(589720)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科创创新药ETF国泰,589720,科创创新药ETF国泰股票,科创创新药ETF国泰股票老虎,科创创新药ETF国泰股票老虎国际,科创创新药ETF国泰行情,科创创新药ETF国泰股票行情,科创创新药ETF国泰股价,科创创新药ETF国泰股市,科创创新药ETF国泰股票价格,科创创新药ETF国泰股票交易,科创创新药ETF国泰股票购买,科创创新药ETF国泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科创创新药ETF国泰(589720)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科创创新药ETF国泰(589720)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}